Cargando…

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling

The molecular profiling of circulating tumor DNA (ctDNA) is a helpful tool not only in cancer treatment, but also in the early detection of relapse. However, the clinical interpretation of a ctDNA negative result remains challenging. The characterization of circulating nucleosomes (carrying cell-fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grolleau, Emmanuel, Candiracci, Julie, Lescuyer, Gaelle, Barthelemy, David, Benzerdjeb, Nazim, Haon, Christine, Geiguer, Florence, Raffin, Margaux, Hardat, Nathalie, Balandier, Julie, Rabeuf, Rémi, Chalabreysse, Lara, Wozny, Anne-Sophie, Rommelaere, Guillaume, Rodriguez-Lafrasse, Claire, Subtil, Fabien, Couraud, Sébastien, Herzog, Marielle, Payen-Gay, Lea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452235/ https://www.ncbi.nlm.nih.gov/pubmed/37627320 http://dx.doi.org/10.3390/biom13081255

Ejemplares similares

Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays
por: Barthelemy, David, et al.
Publicado: (2023)

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept
por: Rousset, Xavier, et al.
Publicado: (2022)

Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM(TM)EGFR V2 and NGS Technologies
por: Garcia, Jessica, et al.
Publicado: (2021)

Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells
por: Garcia, Jessica, et al.
Publicado: (2019)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Evaluation of pre-analytical conditions and comparison of the performance of several digital PCR assays for the detection of major EGFR mutations in circulating DNA from non-small cell lung cancers: the CIRCAN_0 study
por: Garcia, Jessica, et al.
Publicado: (2017)

Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2023)

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)

Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017)

Circulating Tumor Cell Detection during Neoadjuvant Chemotherapy to Predict Early Response in Locally Advanced Oropharyngeal Cancers: A Prospective Pilot Study
por: Gauthier, Arnaud, et al.
Publicado: (2022)

A novel proteomics approach to epigenetic profiling of circulating nucleosomes
por: Van den Ackerveken, Priscilla, et al.
Publicado: (2021)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer
por: Wilson-Robles, Heather, et al.
Publicado: (2020)

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
por: Cavalier, Etienne, et al.
Publicado: (2021)

A new nucleosomic-based model to identify and diagnose SSc-ILD
por: Guiot, Julien, et al.
Publicado: (2020)

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
por: Rahier, Jean-François, et al.
Publicado: (2017)

Characterizing circulating nucleosomes in the plasma of dogs with lymphoma
por: Dolan, Christopher, et al.
Publicado: (2021)

Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma
por: Wilson-Robles, Heather, et al.
Publicado: (2021)

Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools
por: Garcia, Jessica, et al.
Publicado: (2021)

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
por: Morimont, Laure, et al.
Publicado: (2022)

Circulating nucleosomes as predictive markers of severe acute pancreatitis
por: Penttilä, Anne K., et al.
Publicado: (2016)

UKLS trial: looking beyond negative results
por: Darrason, Marie, et al.
Publicado: (2021)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2016)

The ‘stealth-bomber’ paradigm for deciphering the tumour response to carbon-ion irradiation
por: Wozny, Anne-Sophie, et al.
Publicado: (2023)

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
por: Gezer, Ugur, et al.
Publicado: (2015)

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
por: Garcia, Jessica, et al.
Publicado: (2018)

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
por: De Sarkar, Navonil, et al.
Publicado: (2023)

Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes
por: Ponio, Julie Boyer-Di, et al.
Publicado: (2014)

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
por: Kohles, Nikolaus, et al.
Publicado: (2011)

Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients
por: Ito, Hiroaki, et al.
Publicado: (2015)

Are general circulation models obsolete?
por: Balaji, V., et al.
Publicado: (2022)

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
por: Roth, Carina, et al.
Publicado: (2011)

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
por: Fahmueller, Yvonne Nadine, et al.
Publicado: (2012)

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
por: Descotes, Françoise, et al.
Publicado: (2017)

Circulation and Chemotaxis of Fetal Hematopoietic Stem Cells
por: Christensen, Julie L, et al.
Publicado: (2004)

Exercise increases endostatin in circulation of healthy volunteers
por: Gu, Jian-Wei, et al.
Publicado: (2004)

Circulating Tumour DNA in Melanoma—Clinic Ready?
por: Tivey, Ann, et al.
Publicado: (2022)

The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients
por: Navarro-Sobrino, Míriam, et al.
Publicado: (2013)

CIRCULATION
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_ef8qcaef3kvleg8q1n36fipj95